IRIDEX Corporation (IRIX) financial statements (2021 and earlier)

Company profile

Business Address 1212 TERRA BELLA AVE
MOUNTAIN VIEW, CA 94043
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12132122241013
Cash and cash equivalents12132122241013
Receivables79981098
Inventory, net of allowances, customer advances and progress billings689912119
Inventory689912119
Deferred tax assets    2
Other undisclosed current assets1011001
Total current assets:25314039463133
Noncurrent Assets
Operating lease, right-of-use asset13
Property, plant and equipment0111211
Intangible assets, net (including goodwill)1111111
Goodwill1111111
Intangible assets, net (excluding goodwill)0000000
Other noncurrent assets0000000
Deferred tax assets, net   97
Total noncurrent assets:34222119
TOTAL ASSETS:28354242484242
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5786665
Accounts payable1332222
Accrued liabilities2232222
Employee-related liabilities2232222
Taxes payable      0
Deferred revenue11
Debt11     
Deferred revenue and credits3111
Customer advances and deposits   1
Contract with customer, liability2
Other undisclosed current liabilities201211(0)
Total current liabilities:9101110877
Noncurrent Liabilities
Long-term debt and lease obligation02     
Operating lease, liability02
Liabilities, other than long-term debt011111 
Accounts payable and accrued liabilities0000   
Deferred revenue00
Other liabilities000111 
Other undisclosed noncurrent liabilities1     1
Total noncurrent liabilities:2211111
Total liabilities:11121211988
Stockholders' equity
Stockholders' equity attributable to parent17233031393434
Common stock0000000
Additional paid in capital74737259553839
Accumulated other comprehensive income (loss)(0)00    
Accumulated deficit(57)(51)(42)(29)(16)(4)(5)
Total stockholders' equity:17233031393434
TOTAL LIABILITIES AND EQUITY:28354242484242

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues36434342464243
Cost of revenue(21)(26)(25)(26)(25)(22)(21)
Gross profit:16181716212021
Operating expenses(22)(27)(30)(28)(23)(20)(19)
Operating income (loss):(7)(9)(13)(13)(3)03
Nonoperating income (expense)000(0)(0)0 
Income (loss) from continuing operations before equity method investments, income taxes:(6)(9)(13)(13)(3)03
Other undisclosed loss from continuing operations before income taxes      (1)
Income (loss) from continuing operations before income taxes:(6)(9)(13)(13)(3)01
Income tax expense (benefit)(0)(0)(0)0(9)09
Net income (loss) available to common stockholders, diluted:(6)(9)(13)(13)(12)010

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(6)(9)(13)(13)(12)010
Other comprehensive income (loss)(0)00    
Comprehensive income (loss), net of tax, attributable to parent:(6)(9)(13)(13)(12)010

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: